Engineered protein treatment found to reduce obesity in mice, rats and primates

A team of researchers with pharmaceutical company Amgen Inc. report that an engineered version of a protein naturally found in the body caused test mice, rats and cynomolgus monkeys to lose weight. 

Obesity is a growing problem around the world as people consume foods high in carbohydrates and/or sugars as part of a hectic or low-income lifestyle. To address the problem, a weight loss product industry has arisen, offering mixed results. In the meantime, scientists continue to search for therapies to prevent weight gain or to safely lose weight that has already been gained.

In this new effort, the researchers focused on the protein GDF15 – it is produced naturally by the body, and has been found to play a role in metabolic processing. The team at Amgen took note of prior research that showed that lean animals and people tend to have more of it in their bodies.

Other researchers have taken also note of the power of GDF15, and several studies have shown that injecting it into test animals led to weight loss. But such efforts have been stymied by the tendency of the body to clear the extra protein much too quickly for it to be of much use. To overcome that problem, the team at Amgen added a small part of an antibody to the protein, causing it to remain in the body much longer – long enough to induce weight loss when injected once a week. It also resulted in lowered insulin and cholesterol levels in the blood.

The researchers acknowledge that they do not know why raising levels of GDF15 in the body led to weight loss in test animals, but suspect it is tied to the way the protein interacts with nerve and chemical pathways.